Peroxisome Proliferator-Activated Receptor-Gamma Reduces ER Stress and Inflammation via Targeting NGBR Expression

• Published in: Frontiers in pharmacology 2022-01, Vol.12, p.817784-817784
• Main Authors: Ma, Jialing, Zeng, Peng, Liu, Lipei, Zhu, Mengmeng, Zheng, Juan, Wang, Chengyi, Zhao, Xiaokang, Hu, Wenquan, Yang, Xiaoxiao, Duan, Yajun, Han, Jihong, Miao, Qing R, Chen, Yuanli
• Format: Article
• Language: English
• Subjects: ER stress; inflammation; NGBR; Pharmacology; PPARγ; rosiglitazone
• ISSN: 1663-9812; 1663-9812
• DOI: 10.3389/fphar.2021.817784

Increased Nogo-B receptor (NGBR) expression in the liver improves insulin sensitivity by reducing endoplasmic reticulum stress (ER stress) and activating the AMPK pathway, although it remains elusive the mechanisms by which NGBR is induced. In this study, we found that PPARγ ligands (rosiglitazone or pioglitazone) increased NGBR expression in hepatic cells and HUVECs. Furthermore, promoter analysis defined two PPREs (PPARγ-responsive elements) in the promoter region of NGBR, which was further confirmed by the ChIP assay. , using liver-specific PPARγ deficient (PPARγ ) mice, we identified the key role of PPARγ expression in pioglitazone-induced NGBR expression. Meanwhile, the basal level of ER stress and inflammation was slightly increased by NGBR knockdown. However, the inhibitory effect of rosiglitazone on inflammation was abolished while rosiglitazone-inhibited ER stress was weakened by NGBR knockdown. Taken together, these findings show that NGBR is a previously unrecognized target of PPARγ activation and plays an essential role in PPARγ-reduced ER stress and inflammation.